J.M. Arbour’s Pfizer PFE Stock Holding History

J.M. Arbour’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$257K	Buy	9,157 +351	+4%	+$9.35K	0.25%	101
2025 Q4	$219K	Buy	+8,806	New	+$222K	0.22%	105

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

J.M. Arbour's PFE Position: Q1 2026 in Review

J.M. Arbour increased its Pfizer (PFE) stake by 4% in Q1 2026, buying an estimated $9.35K and bringing the position to 9,157 shares worth $257K. The position accounts for 0.25% of the portfolio, ranked #101.

J.M. Arbour first reported a position in PFE in Q4 2025 and has held it in 2 quarters since. 2,946 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

J.M. Arbour held 9,157 shares of Pfizer worth $257K as of Q1 2026.
J.M. Arbour bought 351 Pfizer shares in Q1 2026, an estimated $9.35K.
Pfizer made up 0.25% of J.M. Arbour's portfolio in Q1 2026, its #101 holding.
J.M. Arbour first reported a position in Pfizer in Q4 2025 and has held it in 2 quarters since.
2,946 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on J.M. Arbour's 13F filing for Q1 2026, filed 21 Apr 2026.